(Q36664802)

15 August 2017

1 reference

title

Thrombelastography: current clinical applications and its potential role in interventional cardiology (English)

1 reference

15 August 2017

Hobson AR

1

1 reference

15 August 2017

Agarwala RA

2

1 reference

15 August 2017

Swallow RA

3

1 reference

15 August 2017

Dawkins KD

4

1 reference

15 August 2017

Curzen NP

5

1 reference

15 August 2017

publication date

1 December 2006

1 reference

15 August 2017

1 reference

15 August 2017

volume

17

1 reference

15 August 2017

issue

8

1 reference

15 August 2017

page(s)

509-518

1 reference

Value of thromboelastography in the assessment of platelet function

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F09537100600935259

Bleeding in a patient receiving platelet aggregation inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600935259

Usefulness of thrombelastography in assessment of trauma patient coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600935259

Thromboelastography as an indicator of post-cardiopulmonary bypass coagulopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600935259

Aprotinin prevents bleeding and has effects on platelets and fibrinolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600935259

Thromboelastography: past, present, and future.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600935259

Thrombelastography/thromboelastometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600935259

Haemostatic problems in liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600935259

Thrombelastography after aspirin ingestion in pregnant and non-pregnant subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600935259

Effects of hypothermia on thrombelastography in patients undergoing cardiopulmonary bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600935259

Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600935259

Monitoring of clopidogrel action: comparison of methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600935259

Coronary angioplasty enhances platelet reactivity through von Willebrand factor release

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600935259

Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600935259

Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600935259

Clopidogrel (Plavix) and cardiac surgical patients: implications for platelet function monitoring and postoperative bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600935259

Thromboelastography: potential bedside tool to assess the effects of antiplatelet therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600935259

A novel modification of the Thrombelastograph assay, isolating platelet function, correlates with optical platelet aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600935259

Frequency of nonresponse antiplatelet activity of clopidogrel during pretreatment for cardiac catheterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600935259

Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600935259

Near-site monitoring of the antiplatelet drug abciximab using the Hemodyne analyzer and modified thrombelastograph.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600935259

Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600935259

Aspirin as an antiplatelet drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600935259

Profile and prevalence of aspirin resistance in patients with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600935259

Resistance to aspirin in vitro at rest and during exercise in patients with angiographically proven coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600935259

Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600935259

Compliance as a critical consideration in patients who appear to be resistant to aspirin after healing of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600935259

A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600935259

Resistance to aspirin in vitro is associated with increased platelet sensitivity to adenosine diphosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600935259

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600935259

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600935259

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600935259

Individual variations of platelet inhibition after loading doses of clopidogrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600935259

Platelet adhesion and aggregation in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600935259

Obesity is associated with impaired platelet-inhibitory effect of acetylsalicylic acid in nondiabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600935259

Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600935259

Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting : the clopidogrel aspirin stent international cooperative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600935259

Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600935259

Late angiographic stent thrombosis (LAST) events with drug-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600935259

Stent thrombosis is associated with an impaired response to antiplatelet therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600935259

Clopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600935259

Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600935259

10.1080/09537100600935259

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference